Effects of Low Doses of L-Carnitine Tartrate and Lipid Multi-Particulate Formulated Creatine Monohydrate on Muscle Protein Synthesis in Myoblasts and Bioavailability in Humans and Rodents
Fielding RA, Rivas D, Grosicki GJ, Ezzyat Y, Ceglia L, Price LL, Orhan C, Sahin K, Fowler K, White T, Durkee S, Kritsch K, Bellamine A
Nutrients · 2 citas
Etiquetas de revisión
Vínculos de autores con la industriaFinanciado por la industriaSolo mecanismosDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (indexado por PubMed)
- Estudiado en
- Personas, más trabajo en animales o laboratorio
- Resultado principal
- Solo mecanismos
Quién lo pagó
- Financiación
- Financiado por la industria
- Gobierno
- National Institute on Aging
- Gobierno
- National Center for Advancing Translational Sciences
- Gobierno
- NIA NIH HHS
- Gobierno
- NCATS NIH HHS
- Autores
- Al menos un autor declara un vínculo económico con la industria
- Subvenciones
- National Center for Advancing Translational Sciences (UL1 TR002544); National Institute on Aging (P30-AG031679)
Según 4 financiadores declarados y la declaración de financiación del texto completo.
Publicación
- Publicado
- 2021-11-09 · Nutrients · vol. 13 · número 11 · pág. 3985
- Editorial
- Multidisciplinary Digital Publishing Institute
- Citado
- 3 citas · más que el 38% de estudios similares · 0.1× el promedio de su campo
- Referencias
- 28 trabajos
- Acceso
- Acceso abierto (revista) · CC-BY
- Áreas de investigación
- Muscle metabolism and nutrition · Muscle Physiology and Disorders · Metabolism and Genetic Disorders
- Palabras clave
- Creatine, Carnitine, Bioavailability, Endocrinology, Internal medicine, Chemistry, Creatine Monohydrate, Creatine kinase, Anabolism, Myocyte, Pharmacology, Biochemistry, Medicine
- MeSH
- cells, cultured, myoblasts, animals, humans, rats, rats, wistar, creatine, lipids, carnitine, muscle proteins, ribosomal protein s6, signal transduction, protein biosynthesis, biological availability, phosphorylation, adolescent, adult, female, male, proto-oncogene proteins c-akt, young adult
13 autores
- Roger A. Fielding🇺🇸 · autor de correspondenciaTufts University
- Donato Americo Rivas🇺🇸Tufts University
- Gregory J. Grosicki🇺🇸Tufts University; Georgia Southern University
- Yassine Ezzyat🇺🇸Tufts University
- Lisa Ceglia🇺🇸Tufts Medical Center
- Lori Lyn Price🇺🇸Tufts University; Tufts Medical Center
- Cemal Orhan🇹🇷Fırat University
- Kazım Şahin🇹🇷Fırat University
- Kelli Fowler🇺🇸Lonza (United States)
- Tyler White🇺🇸Lonza (United States)
- Shane Durkee🇺🇸Lonza (United States)
- Katja Kritsch🇺🇸Lonza (United States)
- Aouatef Bellamine🇺🇸Lonza (United States)
Resumen
El texto original del estudio, en el idioma en que se publicó.
The primary objective of this study was to investigate the potential synergy between low doses of L-carnitine tartrate and creatine monohydrate to induce muscle protein synthesis and anabolic pathway activation in primary human myoblasts. In addition, the effects of Lipid multi-particulates (LMP) formulation on creatine stability and bioavailability were assessed in rodents and healthy human subjects. When used individually, L-carnitine tartrate at 50 µM and creatine monohydrate at 0.5 µM did not affect myoblast protein synthesis and signaling. However, when combined, they led to a significant increase in protein synthesis. Increased AKT and RPS6 phosphorylation were observed with 50 µM L-carnitine tartrate 5 µM creatine in combination in primary human myoblasts. When Wistar rats were administered creatine with LMP formulation at either 21 or 51 mg/kg, bioavailability was increased by 27% based on the increase in the area under the curve (AUC) at a 51 mg/kg dose compared to without LMP formulation. Tmax and Cmax were unchanged. Finally, in human subjects, a combination of LMP formulated L-carnitine at 500 mg (from L-carnitine tartrate) with LMP formulated creatine at 100, 200, or 500 mg revealed a significant and dose-dependent increase in plasma creatine concentrations. Serum total L-carnitine levels rose in a similar manner in the three combinations. These results suggest that a combination of low doses of L-carnitine tartrate and creatine monohydrate may lead to a significant and synergistic enhancement of muscle protein synthesis and activation of anabolic signaling. In addition, the LMP formulation of creatine improved its bioavailability. L-carnitine at 500 mg and LMP-formulated creatine at 200 or 500 mg may be useful for future clinical trials to evaluate the effects on muscle protein synthesis.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.